IDEXX Laboratories, Inc. (IDXX)

Market Cap	41.03B
Revenue (ttm)	3.66B
Net Income (ttm)	845.04M
Shares Out	83.09M
EPS (ttm)	10.06
PE Ratio	49.11
Forward PE	43.41
Dividend	n/a
Ex-Dividend Date	n/a

Volume	558,266
Open	482.60
Previous Close	479.57
Day's Range	480.16 - 494.45
52-Week Range	372.50 - 583.39
Beta	1.26
Analysts	Buy
Price Target	588.57 (+19.19%)
Earnings Date	May 1, 2024

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnos...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 21, 1991
• Employees: 11,000
• Stock Exchange: NASDAQ
• Ticker Symbol: IDXX

Financial Performance

In 2023, IDXX's revenue was $3.66 billion, an increase of 8.72% compared to the previous year's $3.37 billion. Earnings were $845.04 million, an increase of 24.44%.

Analyst Forecast

According to 7 analysts, the average rating for IDXX stock is "Buy." The 12-month stock price forecast is $588.57, which is an increase of 19.19% from the latest price.

Price Target

$588.57

(19.19% upside)

Analyst Consensus: Buy